Kojin is pioneering cell-state and ferroptosis biology and cutting-edge drug discovery to develop first-in-class small-molecule treatments that modulate ferroptosis.

Biotechnology

Kojin Therapeutics

Harvey J. Berger

Narayana Narasimhan

Wei-Sheng Huang

David Dalgarno

Horst Hemmerle

Kojin Therapeutics' CEO and Executive Team includes Kay Ahn and 1 others.

CEO and Executive Team

About

Team members

Other teams at Kojin Therapeutics

Founding Team